Livia C. Ferreira

Sao Jose Do Rio Preto, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells.

Journal: PloS one
Published: February 26, 2019

Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.

Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.

Journal: MicroRNA (Shariqah, United Arab Emirates)
Published: October 31, 2018

Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.

Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.

Journal: Life sciences
Published: May 05, 2018

Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.

Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.

Journal: Anti-cancer agents in medicinal chemistry
Published: April 24, 2018

Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.

Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.

Journal: Anti-cancer agents in medicinal chemistry
Published: May 17, 2016

Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.

Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.

Journal: Journal of pineal research
Published: June 29, 2015

Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.

Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.

Journal: Oncology letters
Published: March 12, 2015

Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.

Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.

Journal: Anti-cancer agents in medicinal chemistry
Published: November 28, 2014

Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.

Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.

Journal: Oncology reports
Published: October 08, 2014

Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer.

Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer.

Journal: Anti-cancer agents in medicinal chemistry
Published: October 01, 2014

HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.

HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.

Journal: PloS one
Published: June 04, 2014

Evaluation of melatonin treatment in primary culture of canine mammary tumors.

Evaluation of melatonin treatment in primary culture of canine mammary tumors.

Journal: Oncology reports
Published: May 16, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026